ABBOTT LABORATORI…
USUSDABBOTT LABORATORIES (MX:ABT) — Biotechnology: Pharmaceutical Preparations. Liczba giełd, na których notowane są akcje spółki: 4. Na tej stronie — cena i wykres, dywidendy, najwięksi akcjonariusze oraz historia liczby akcji.
O Firmie
- Strona
- abbott.com
- Sektor
- Health Care · Biotechnology: Pharmaceutical Preparations
- Siedziba
- North Chicago, United States
- Prezes
- Robert Ford
- Pracownicy
- 73 000
- Założona
- 1888
- Notowana od
- 16.03.2005 (MX:ABT)
- Akcje w Obrocie
- 1.73 mld na 2026-06-30
- Free Float
- 1.72 mld
- Kapitalizacja Rynkowa
- 169.83 mld USD
- Insiderzy
- 0.49%
- Inwestorzy Instytucjonalni
- 81.79%
- Branża (SIC)
- Pharmaceutical Preparations
- Forma Prawna
- AZUK
- ISIN
- US0028241000
- LEI
- HQD377W2YR662HK5JX27
- P/E
- 34.7
- Stopa Wypłaty
- 66.7%
- FCF
- 7.38 mld USD
- Wypłaty / FCF
- 57%
- Dług
- 34.0 mld USD3.7 l. FCF
- Staż Dywidendowy
- 43 l.
- Zysk, FCF i wypłacone dywidendy — za 12 miesięcy do 31.03.2026 (najnowszy raport spółki).
- NAV
Opis
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.
Dywidendy
ABBOTT LABORATORIES (ABT) wypłaca dywidendy kwartalnie. Na rok (12 miesięcy do ostatniej ogłoszonej płatności): 45.9768 MXN na akcję (płatności: 4). To około 2.38% obecnej ceny akcji. Na podstawie historii wypłat następna data ex-dywidendy spodziewana jest około 15.01.2027. Lata nieprzerwanych dywidend: 43.
| Dzień Ex | Wypłata | Kwota | % | Typ | Ticker |
|---|---|---|---|---|---|
| 2026-10-15 | — | 11.6147 MXN | 0.6/2.4 % | kwartalnie | MX:ABT |
| 2026-07-15 | — | 11.4540 MXN | 0.7/2.9 % | kwartalnie | MX:ABT |
| 2026-04-15 | — | 11.4540 MXN | 0.7/2.5 % | kwartalnie | MX:ABT |
| 2026-01-15 | — | 11.4540 MXN | 0.5/1.9 % | kwartalnie | MX:ABT |
| 2025-10-15 | — | 10.7268 MXN | 0.4/1.8 % | kwartalnie | MX:ABT |
| 2025-07-15 | — | 10.7268 MXN | 0.4/1.7 % | kwartalnie | MX:ABT |
| 2025-04-15 | — | 10.7268 MXN | 0.4/1.6 % | kwartalnie | MX:ABT |
| 2025-01-15 | — | 10.7268 MXN | 0.5/1.7 % | kwartalnie | MX:ABT |
| 2024-10-15 | — | 9.9996 MXN | 0.5/1.8 % | kwartalnie | MX:ABT |
| 2024-07-15 | — | 9.9996 MXN | 0.5/2.1 % | kwartalnie | MX:ABT |
| 2024-04-12 | — | 9.9996 MXN | 0.5/2.1 % | kwartalnie | MX:ABT |
| 2024-01-11 | — | 9.9996 MXN | 0.5/2.0 % | kwartalnie | MX:ABT |
| 2023-10-12 | — | 9.2723 MXN | 0.6/2.2 % | kwartalnie | MX:ABT |
| 2023-07-13 | — | 9.2723 MXN | 0.5/2.0 % | kwartalnie | MX:ABT |
| 2023-04-13 | — | 9.2723 MXN | 0.5/1.9 % | kwartalnie | MX:ABT |
| 2023-01-12 | — | 9.2723 MXN | 0.4/1.6 % | kwartalnie | MX:ABT |
| 2022-10-13 | — | 8.5451 MXN | 0.4/1.7 % | kwartalnie | MX:ABT |
| 2022-07-14 | — | 8.5451 MXN | 0.4/1.2 % | kwartalnie | MX:ABT |
| 2022-04-13 | — | 8.5451 MXN | 0.4/0.7 % | kwartalnie | MX:ABT |
| 2022-01-13 | — | 8.5451 MXN | 0.3/0.3 % | kwartalnie | MX:ABT |
Wiadomości w Tym Tygodniu
Komunikaty prasowe ze strony firmy dla inwestorów, aktualizowane codziennie. Linki prowadzą na stronę firmy. Nagłówki są w oryginalnym języku, jak na stronie internetowej firmy.
| 13.10.2026 | Newsroom | Top Stories |
| 12.10.2026 | Newsroom | Top Stories |
Najwięksi Akcjonariusze
| Posiadacz | Udział | Akcje | Data Raportu |
|---|---|---|---|
| BlackRock | 8.82% | 152.56 mln | 2026-06-30 |
| Vanguard Capital Managem… | 6.57% | 113.75 mln | 2026-06-30 |
| State Street Corporation | 4.68% | 80.93 mln | 2026-06-30 |
| Charles Schwab Investmen… | 3.45% | 59.67 mln | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.2% | 55.3 mln | 2026-06-30 |
| Vanguard Portfolio Manag… | 2.83% | 49.02 mln | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.61% | 45.14 mln | 2026-06-30 |
| Geode Capital Management… | 2.27% | 39.22 mln | 2026-06-30 |
| Capital Research Global… | 2.13% | 36.91 mln | 2026-06-30 |
| Capital International In… | 2% | 34.65 mln | 2026-06-30 |
| SCHWAB STRATEGIC TRUST-S… | 1.9% | 32.82 mln | 2026-05-31 |
| Morgan Stanley | 1.54% | 26.61 mln | 2026-06-30 |
| NORGES BANK | 1.35% | 23.35 mln | 2026-06-30 |
| iShares Trust-iShares Co… | 1.34% | 23.2 mln | 2026-08-31 |
| Fidelity Concord Street… | 1.3% | 22.52 mln | 2026-07-31 |
| SPDR S&P 500 ETF TRUST-S… | 1.23% | 21.31 mln | 2026-08-31 |
| WASHINGTON MUTUAL INVEST… | 1.01% | 17.53 mln | 2026-07-31 |
| VANGUARD INDEX FUNDS-Van… | 0.96% | 16.58 mln | 2026-06-30 |
| SELECT SECTOR SPDR TRT-S… | 0.72% | 12.52 mln | 2026-08-31 |
| Investment Co of America | 0.6% | 10.33 mln | 2026-06-30 |
| STARKS DANIEL J (Directo… | ≈0.39% | 6.75 mln | 2026-04-27 |
| FORD ROBERT B. (Chief Ex… | ≈0.03% | 522 664 | 2026-08-25 |
| ALLEN HUBERT L. (Officer… | ≈0.01% | 200 281 | 2025-02-25 |
| SALVADORI DANIEL GESUA S… | ≈0.01% | 146 377 | 2026-03-02 |
| CONROY KEVIN T (Director… | ≈0.01% | 133 737 | 2026-04-24 |
| MORELAND MARY K (Officer… | ≈0.01% | 116 136 | 2026-03-02 |
| EARNHARDT LISA D (Office… | ≈0.01% | 98 984 | 2026-02-24 |
| SCOGGINS CHRISTOPHER J (… | ≈0% | 82 123 | 2026-02-24 |
| WAINER ANDREA F (Officer… | ≈0% | 74 381 | 2025-03-03 |
| The Vanguard Group | — | — | — |
| BOUDREAU PHILIP P (Chief… | — | — | 2026-04-23 |
